Fact CheckerSign in

NCT04566341Enrolling by invitation

Study of Gastrointestinal Dysfunction and Enteric Neural Pathology in Patients With Parkinson's Disease

Source: ClinicalTrials.gov · Last updated 22 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The goal of this research is to determine (1) the feasibility of tethered capsule OCT esophageal imaging in the Parkinson's Disease population; (2) the morphologic changes in the enteric nervous system of the esophagus in patients with Parkinson's disease.

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
20 (estimated)
First submitted
11 Aug 2020
Start date
4 May 2019
Primary completion date
31 Dec 2027
Lead sponsor
Massachusetts General Hospital
NCT number
NCT04566341

What you commit to

  • Study type: Observational
  • Planned participants: 20
  • From 4 May 2019 to the primary completion date, 31 Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Recent intestinal resection (within the last six months)
  • Prior gastric, esophageal or oropharyngeal surgery

Other illness

  • Atypical or secondary Parkinson Disease
  • Esophageal fistula and/or esophageal strictures with a luminal stricture diameter that is smaller than the diameter of the capsule

Other

  • Inability to swallow capsules
  • Pregnancy, according to participant information

Who the study is looking for

  • Idiopathic Parkinson's disease as defined by the United Kingdom PD Society Brain Bank Criteria
  • Parkinson Disease Hoehn and Yahr stage 2-4
  • Participants on stable dose of Parkinson Disease medications for at least 4 weeks prior to the study screening
  • Participants between 40 and 85 years old
  • Participants who are capable of giving informed consent

Age in the registry: 40 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Massachusetts General Hospital
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.